USP28 and pachyonychia congenita: Taken together, these results suggest that USP28 contributes to PC pathogenesis via enhancing the FOXM1-mediated Wnt/β-catenin signalling (Fig. 7I), thereby indicating that targeting USP28/FOXM1/β-catenin axis could be a potential strategy for PC therapy.